These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8799871)

  • 1. Synthesis, physical properties, toxicological studies and bioavailability of L-pyroglutamic and L-glutamic acid esters of paracetamol as potentially useful prodrugs.
    Bousquet E; Marrazzo A; Puglisi G; Spadaro A; Tirendi S
    J Pharm Pharmacol; 1996 May; 48(5):479-85. PubMed ID: 8799871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol.
    Santos C; Mateus ML; dos Santos AP; Moreira R; de Oliveira E; Gomes P
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1595-8. PubMed ID: 15745804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
    Mahfouz NM; Hassan MA
    J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential chemoprotection against acetaminophen-induced hepatotoxicity by latentiated L-cysteines.
    Roberts JC; Phaneuf HL; Szakacs JG; Zera RT; Lamb JG; Franklin MR
    Chem Res Toxicol; 1998 Nov; 11(11):1274-82. PubMed ID: 9815187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-prodrugs of L-cysteine: differential protection against acetaminophen-induced hepatotoxicity in mice.
    Crankshaw DL; Berkeley LI; Cohen JF; Shirota FN; Nagasawa HT
    J Biochem Mol Toxicol; 2002; 16(5):235-44. PubMed ID: 12439865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of acetaminophen proline prodrug.
    Wu Z; Patel A; Dave R; Yuan X
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3851-4. PubMed ID: 20627561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use.
    Depré M; van Hecken A; Verbesselt R; Tjandra-Maga TB; Gerin M; de Schepper PJ
    Fundam Clin Pharmacol; 1992; 6(6):259-62. PubMed ID: 1487229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
    Aboul-Fadl T; Al-Hamad SS; Fouad EA
    Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine reduces the hepatotoxicity of paracetamol in mice.
    Raińska T; Juzwiak S; Dutkiewicz T; Krasowska B; Olenderek B; Roźéwicka L; Wójcicki J; Samochowiec L; Juzyszyn Z
    J Int Med Res; 1992 Aug; 20(4):331-42. PubMed ID: 1511772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability.
    Orioli M; Vistoli G; Regazzoni L; Pedretti A; Lapolla A; Rossoni G; Canevotti R; Gamberoni L; Previtali M; Carini M; Aldini G
    ChemMedChem; 2011 Jul; 6(7):1269-82. PubMed ID: 21634010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxicological relevance of paracetamol-induced inhibition of hepatic respiration and ATP depletion.
    Strubelt O; Younes M
    Biochem Pharmacol; 1992 Jul; 44(1):163-70. PubMed ID: 1632830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracetamol (acetaminophen) esters of some non-steroidal anti-inflammatory carboxylic acids as mutual prodrugs with improved therapeutic index.
    Fadl TA; Omar FA
    Inflammopharmacology; 1998; 6(2):143-57. PubMed ID: 17694371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of mgs0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid), a potent metabotropic glutamate receptor antagonist.
    Nakamura M; Kawakita Y; Yasuhara A; Fukasawa Y; Yoshida K; Sakagami K; Nakazato A
    Drug Metab Dispos; 2006 Mar; 34(3):369-74. PubMed ID: 16326817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methyl-thiazolidine-2,4-dicarboxylic acid as prodrug of L-cysteine. Protection against paracetamol hepatotoxicity in mice.
    Wlodek L; Rommelspacher H
    Fundam Clin Pharmacol; 1997; 11(5):454-9. PubMed ID: 9342599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic delivery of glutathione by conjugation to dextran.
    Kaneo Y; Fujihara Y; Tanaka T; Kozawa Y; Mori H; Iguchi S
    Pharm Res; 1989 Dec; 6(12):1025-31. PubMed ID: 2482968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of 2',3'-dideoxyinosine (DDI): improved oral bioavailability via hydrophobic esters.
    Kawaguchi T; Hasegawa T; Seki T; Juni K; Morimoto Y; Miyakawa A; Saneyoshi M
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1338-40. PubMed ID: 1394659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vivo evaluation of prodrugs of 9-[2-(phosphonomethoxy)ethoxy]adenine.
    Serafinowska HT; Ashton RJ; Bailey S; Harnden MR; Jackson SM; Sutton D
    J Med Chem; 1995 Apr; 38(8):1372-9. PubMed ID: 7731022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.